Review


DOI :10.26650/IUITFD.2020.0015   IUP :10.26650/IUITFD.2020.0015    Full Text (PDF)

NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER

Sema Bolkent

In recent years, a new mechanism for intercellular communication has been put forward which involves the intercellular transfer of extracellular vesicles. Most cancer cells release potentially functional biomolecules loaded in extracellular vesicles (EVs) such as DNA, proteins, lipids, and microRNAs. The experiments showed that EVs uptake by tumor cells can alter cellular behavior. Exosomes, a subtype of EVs, are small, lipid bilayer membrane vesicles for intercellular communication. Exosomes communicate with near-by and distant cancer cells that promote cancer development, metastasis, and drug resistance. In addition to intercellular communication, exosomes play a role in many biological processes such as signal transmission, genetic material transfer, and regulation of the immune response. EVs have emerged as an alternative mediator of communication within the tumor microenvironment and cancer metastasis. Because exosomes can change their content during various cancer treatments, they can play an important role in following the treatment. This review focuses on the function of EVs as signal transmitters between cells, called communicasomes (intercellular communication), and the importance of this function in cancer diagnosis and treatment.

DOI :10.26650/IUITFD.2020.0015   IUP :10.26650/IUITFD.2020.0015    Full Text (PDF)

KANSERDE YENİ HEDEF: MİKROVEZİKÜLLER VE EKSOZOMLAR

Sema Bolkent

Son yıllarda hücreler arası haberleşmede ekstrasellüler veziküllerin transferini içeren yeni bir mekanizma öne sürülmüştür. Çoğu kanser hücresi protein, lipit, DNA ve mikroRNA’lardan oluşan ekstrasellüler veziküller (EV’ler) salarak komşu hücre davranışının değişmesine neden olabilmektedir. EV’lerin bir alt tipi olan eksozomlar hücreler arası iletişim sağlayan küresel şekilli, iki lipit tabakalı membran ile çevrili keseciklerdir. Eksozomlar kanser gelişimini, metastaz ve ilaç direncini kontrol etmek için yakın ve uzak çevre kanser hücreleri ile iletişim kurarlar. Eksozomlar hücreler arası iletişimin yanısıra sinyal iletimi, genetik madde aktarımı, bağışıklık yanıtının düzenlenmesi gibi birçok biyolojik işlevde rol oynar. EV’lerin tümör mikro çevresinde ve kanser metastazında alternatif bir haberleşme aracı olduğu ortaya çıkarılmıştır. Eksozomlar çeşitli kanser tedavileri esnasında içeriklerini değiştirebildiklerinden dolayı tedaviyi takip etmede önemli bir rol oynayabilirler. Bu derleme kanser tanı ve tedavisinin hedefi olarak komünikazom (hücreler arası haberleşme) olarak adlandırılan hücreler arasında sinyalleri ileten EV’lerin fonksiyonuna odaklanmaktadır


PDF View

References

  • 1. Ariazi J, Benowitz A, De Biasi V, Den Boer ML, Cherqui S, Cui H, et al. Tunneling nanotubes and gap junctions-their role in long-range intercellular communication during development, health, and disease conditions. Front Mol Neurosci 2017;10:333. [CrossRef] google scholar
  • 2. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012;15;21(R1): R125-34. [CrossRef] google scholar
  • 3. Yoon YJ, Kim OY, Gho YS. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep 2014;47(10):531-9. [CrossRef] google scholar
  • 4. Zhao H, Achreja A, Iessi E, Logozzi M, Mizzoni D, Di Raimo R, et al. The key role of extracellular vesicles in the metastatic process. Biochim Biophys Acta 2018;1869(1):64-77. [CrossRef] google scholar
  • 5. Abak A, Abhari A, Rahimzadeh S. Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics. Peer J 2018 29;6:e4763. [CrossRef] google scholar
  • 6. Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of exosome composition. Cell 2019;177(2):428-45. [CrossRef] google scholar
  • 7. Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol 2015;8:83. [CrossRef] google scholar
  • 8. Zomer A, Maynard C, Verweij FJ, Kamermans A, Schäfer R, Beerling E, et al. In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 2015;161(5):1046-57. [CrossRef] google scholar
  • 9. Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 2002;27;360(9329):295- 305. [CrossRef] google scholar
  • 10. Lässer C, Eldh M, Lötvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012;(59):e3037. [CrossRef] google scholar
  • 11. Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 2014;5:3591. [CrossRef] google scholar
  • 12. Choi DS, Kim DK, Kim YK, Gho YS. Proteomics of extracellular vesicles:Exosomes and ectosomes. Mass Spectrom Rev 2015;34(4):474-90. [CrossRef] google scholar
  • 13. Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: A WebBased Compendium of Exosomal Cargo. J Mol Biol 2016;428(4):688-92. [CrossRef] google scholar
  • 14. Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7(1):1535750. [CrossRef] google scholar
  • 15. Trams EG, Lauter CJ, Salem N Jr, Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981;645(1):63-70. [CrossRef] google scholar
  • 16. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013;32(3-4):623-42. [CrossRef] google scholar
  • 17. Zhang G, Yang P. A novel cell-cell communication mechanism in the nervous system: exosomes. J Neurosci Res 2018;96(1):45-52. [CrossRef] google scholar
  • 18. Tian T, Zhu YL, Hu FH, Wang YY, Huang NP, Xiao ZD. Dynamics of exosome internalization and trafficking. J Cell Physiol 2013;228:1487-95. [CrossRef] google scholar
  • 19. Wei Y, Wang D, Jin F, Bian Z, Li L, Liang H, et al. Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23. Nat Commun 2017;8:14041. [CrossRef] google scholar
  • 20. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009;284(49):34211-22. [CrossRef] google scholar
  • 21. Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol 2016;214(2):197-213. [CrossRef] google scholar
  • 22. Zhang Y, Liu F, Yuan Y, Jin C, Chang C, Zhu Y, et al. Inflammasome-derived exosomes activate NF-κB signaling in macrophages. J Proteome Res 2017;16(1):170-8. [CrossRef] google scholar
  • 23. Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J. Exosomes: new molecular targets of diseases. Acta Pharmacol Sin 2018; 39(4):501-13. [CrossRef] google scholar
  • 24. Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 2016;12(3):655-64. [CrossRef] google scholar
  • 25. Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A 2013;110(43):17380-5. [CrossRef] google scholar
  • 26. Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res 2016;18(1):90. [CrossRef] google scholar
  • 27. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A 2016;113(8):E968-77. [CrossRef] google scholar
  • 28. Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010;59 (6):841-50. [CrossRef] google scholar
  • 29. Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: Cell-to-cell mediators of metastasis. Cancer Cell 2016;30(6):836-48. [CrossRef] google scholar
  • 30. Cai Z, Yang F, Yu L, Yu Z, Jiang L, Wang Q, et al. Activated T cell exosomes promote tumor invasion via Fas signaling pathway. J Immunol 2012;15;188(12):5954-61. [CrossRef] google scholar
  • 31. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, et al. Amphiregulin exosomes increase cancer cell invasion. Curr Biol 2011;21(9):779-86. [CrossRef] google scholar
  • 32. Brinton TL, Sloane HS, Kester M, Kelly KA. Formation and role of exosomes in cancer. Cell Mol Life Sci 2015;72(4): 659- 71. [CrossRef] google scholar
  • 33. Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer 2019;18(1):75. [CrossRef] google scholar
  • 34. Melo SA, Sugimoto H, O’Connell JT, Kato N, Villanueva A, Vidal A, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell 2014;26(5):707-21. [CrossRef] google scholar
  • 35. Bach DH, Hong JY, Park HJ, Lee SK. The role of exosomes and miRNAs in drug-resistance of cancer cells. Int J Cancer 2017;141(2):220-30. [CrossRef] google scholar
  • 36. Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer 2018;17(1):147. [CrossRef] google scholar
  • 37. Huang T, Deng CX. Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. Int J BiolSci 2019;15(1):1-11. [CrossRef] google scholar
  • 38. Vaksman O, Tropé C, Davidson B, Reich R. Exosomederived miRNAs and ovarian carcinoma progression. Carcinogenesis 2014;35(9):2113-20. [CrossRef] google scholar
  • 39. Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, et al. Circulating exosomal microRNAs as prognostic biomarkers for non-smallcell lung cancer. Oncotarget 2017;8(8):13048-58. [CrossRef] google scholar
  • 40. Xue X, Liu Y, Wang Y, Meng M, Wang K, Zang X, et al. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget 2016;7(51):84508-19. [CrossRef] google scholar
  • 41. Liu X, Jiang T, Li X, Zhao C, Li J, Zhou F, et al. Exosomes transmit T790M mutation-induced resistance in EGFRmutant NSCLC by activating PI3K/AKT signalling pathway. J Cell Mol Med 2020;24(2):1529-40. [CrossRef] google scholar
  • 42. Lan J, Sun L, Xu F, Liu L, Hu F, Song D, et al. M2 Macrophagederived exosomes promote cell migration and invasion in colon cancer. Cancer Res 2019;79(1):146-58. [CrossRef] google scholar
  • 43. Wu Y, Deng W, McGinley EC, Klinke DJ 2nd. Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function. Pigment Cell Melanoma Res 2017;30(2):203-18. [CrossRef] google scholar
  • 44. Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 2008;16(4):782-90. [CrossRef] google scholar
  • 45. Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology 2015;5(4):e1071008. [CrossRef] google scholar
  • 46. Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 2012;227(2):658-67. [CrossRef] google scholar
  • 47. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008;110(1):13-21. [CrossRef] google scholar
  • 48. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011;2:180. [CrossRef] google scholar
  • 49. Park ES, Kim SJ, Kim SW, Yoon SL, Leem SH, Kim SB, et al. Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis. Proc Natl Acad Sci USA 2011;108(42):17456-61. [CrossRef] google scholar
  • 50. Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 2015;527(7576):100-4. [CrossRef] google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Bolkent, S. (2021). NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER. Journal of Istanbul Faculty of Medicine, 84(1), 130-134. https://doi.org/10.26650/IUITFD.2020.0015


AMA

Bolkent S. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER. Journal of Istanbul Faculty of Medicine. 2021;84(1):130-134. https://doi.org/10.26650/IUITFD.2020.0015


ABNT

Bolkent, S. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 1, p. 130-134, 2021.


Chicago: Author-Date Style

Bolkent, Sema,. 2021. “NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER.” Journal of Istanbul Faculty of Medicine 84, no. 1: 130-134. https://doi.org/10.26650/IUITFD.2020.0015


Chicago: Humanities Style

Bolkent, Sema,. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER.” Journal of Istanbul Faculty of Medicine 84, no. 1 (May. 2024): 130-134. https://doi.org/10.26650/IUITFD.2020.0015


Harvard: Australian Style

Bolkent, S 2021, 'NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER', Journal of Istanbul Faculty of Medicine, vol. 84, no. 1, pp. 130-134, viewed 13 May. 2024, https://doi.org/10.26650/IUITFD.2020.0015


Harvard: Author-Date Style

Bolkent, S. (2021) ‘NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER’, Journal of Istanbul Faculty of Medicine, 84(1), pp. 130-134. https://doi.org/10.26650/IUITFD.2020.0015 (13 May. 2024).


MLA

Bolkent, Sema,. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 1, 2021, pp. 130-134. [Database Container], https://doi.org/10.26650/IUITFD.2020.0015


Vancouver

Bolkent S. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER. Journal of Istanbul Faculty of Medicine [Internet]. 13 May. 2024 [cited 13 May. 2024];84(1):130-134. Available from: https://doi.org/10.26650/IUITFD.2020.0015 doi: 10.26650/IUITFD.2020.0015


ISNAD

Bolkent, Sema. NEW TARGET MICROVESICLES AND EXOSOMES IN CANCER”. Journal of Istanbul Faculty of Medicine 84/1 (May. 2024): 130-134. https://doi.org/10.26650/IUITFD.2020.0015



TIMELINE


Submitted10.02.2020
Accepted26.03.2020
Published Online11.01.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.